Skip to main content

MoneyWorks4Me

Jagsonpal Pharmaceuticals informs about disclosure

18 Sep 2024 Evaluate
Jagsonpal Pharmaceuticals has informed that the exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Infinity Portfolio Holdings.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1371.20
Cipla 1409.00
Lupin 1990.00
Zydus Lifesciences 1195.00
View more..